Figure 1.
Correlation of age with anti-rubella IgG antibody level in pregnant women who sought prenatal care at obstetrics and maternity hospitals affiliated with Shiraz University of Medical Sciences in southern Iran, from November 2011 to January 2012.
Figure 2.
Correlation of gestational age with anti-rubella IgG antibody level in pregnant women who sought prenatal care at obstetrics and maternity hospitals affiliated with Shiraz University of Medical Sciences in southern Iran, from November 2011 to January 2012.
Figure 3.
Correlation of first trimester body mass index with anti-rubella IgG antibody level in pregnant women who sought prenatal care at obstetrics and maternity hospitals affiliated with Shiraz University of Medical Sciences in southern Iran, from November 2011 to January 2012.
Figure 4.
Correlation of age with anti-measles IgG antibody level in pregnant women who sought prenatal care at obstetrics and maternity hospitals affiliated with Shiraz University of Medical Sciences in southern Iran from November 2011 to January 2012.
Figure 5.
Correlation of gestational age with anti-measles IgG antibody level in pregnant women who sought prenatal care at obstetrics and maternity hospitals affiliated with Shiraz University of Medical Sciences in southern Iran from November 2011 to January 2012.
Figure 6.
Correlation of first trimester body mass index with anti-measles IgG antibody level in pregnant women who sought prenatal care at obstetrics and maternity hospitals affiliated with Shiraz University of Medical Sciences in southern Iran from November 2011 to January 2012.
Table 1.
Correlation of demographic and obstetric characteristics and history of medical diseases with anti-rubella IgG and anti-measles IgG antibody concentration in pregnant women who sought prenatal care at obstetrics and maternity hospitals affiliated with Shiraz University of Medical Sciences in southern Iran from November 2011 to January 2012*.
Table 2.
Comparison of demographic and obstetric characteristics between pregnant women with protective and nonprotective levels of rubella or measles IgG who sought prenatal care at obstetrics and maternity hospitals affiliated with Shiraz University of Medical Sciences in southern Iran from November 2011 to January 2012*.